One million dollars in research grants for nine researchers

At the second international scientifi c seminar and grant award ceremony of the GEMI Fund (Gas Enabled Medical Innovations), nine researchers shared a total of USD one million for research into gas enabled medical innovation.

The meeting was held in Stockholm on 15 September, 2005. It also provided the platform for the 2003 GEMI Fund grantees to present findings of the research they have been conducting over the past two years.

Attending were nearly 100 scientists, distinguished guests and grantees, and in his opening address Head of Linde Gas Therapeutics, Lars K�lls�ter noted with satisfaction the notable rise of interest in, and awareness of, the GEMI Fund among the scientifi c and medical community as well as the leading position Linde Gas Therapeutics has established in this fi eld. The GEMI Fund was founded in 2003 by Linde Gas Therapeutics in co-operation with Harvard Medical International of Boston, USA and the Karolinska Institute of Stockholm, Sweden.

The role of Linde Gas Therapeutics as benefactor was highlighted by GEMI Fund Board member, Dr David Pinsky, MD, Professor of Cardiovascular Medicine at the University of Michigan. ‘The GEMI Fund is unique in the world. Here we have industry demonstrating a genuine interest in science. I really feel the Fund’s work is going to leverage further development in the fi eld of gas enabled medical innovation.’

As well as presentations of the fi ndings of the GEMI-funded research, attendees also heard from Professor G�ran Hedenstierna, MD, (from Uppsala University Hospital, Sweden) how, with the support of Linde Gas Therapeutics in the form of gas and devices, he and his Chinese and Swedish team achieved positive outcomes with patients of the SARS epidemic in China.